๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China ยท Delayed Price ยท Currency is CNY
2.900
-0.070 (-2.36%)
Nov 20, 2026, 3:04 PM CST

SHE:300026 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Revenue
3,8994,9415,7836,1096,6507,671
Revenue Growth
-28.99%-14.55%-5.34%-8.14%-13.30%18.22%
Gross Profit
2,3482,7472,9893,2823,8244,403
Operating Income
121.64177.81102.42515.52724.421,002
Net Income
25.7718.521.47506.63624.24687.32
Earnings Per Share
0.010.010.010.170.210.23
EPS Growth
-0%-94.12%-19.05%-8.70%21.05%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '24 Dec '23 Jan '23
Chinese Medicine Formula Granules and Decoction Pieces
2,4612,6692,9233,360
Finished Medicine
1,3771,4291,4401,361
Excipients and APIs
428.24481.51512.61544.75
Medical Instruments
587.931,1211,0981,261
Others
87.281.88134.72123.24
Total
4,9415,7836,1096,650

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Investments
1,6961,5021,3061,5741,2061,316
Total Debt
348.17531.1852.071,5332,0911,965
Net Cash (Debt)
1,348971.06454.1240.24-884.45-648.87
Net Cash Growth
76.44%113.83%1028.45%---
Net Cash Per Share
0.660.530.210.01-0.30-0.22

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Cash Flow
769.1811.34852.241,530745.35391.6
Capital Expenditures
-109.68-130.25-193.12-347.12-770.27-677.45
Free Cash Flow
659.42681.09659.121,183-24.93-285.85
Free Cash Flow Growth
-6.49%3.33%-44.28%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Gross Margin
60.22%55.59%51.69%53.73%57.50%57.40%
Operating Margin
3.12%3.60%1.77%8.44%10.89%13.07%
Pretax Margin
1.70%1.67%0.93%9.93%10.77%11.14%
Profit Margin
0.66%0.37%0.37%8.29%9.39%8.96%
FCF Margin
16.91%13.78%11.40%19.36%-0.38%-3.73%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Dividend Per Share
0.0100.0100.0300.0300.0300.040
Dividend Per Share Growth
-66.67%-66.67%0%0%-25.00%0%
Dividend Yield
0.34%0.28%0.79%0.71%0.53%0.51%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
PE Ratio
228.60571.75530.3825.1427.3434.22
Forward PE
20.7121.3320.2115.4025.2416.83
P/FCF Ratio
13.2115.5317.2710.77--
PS Ratio
2.232.141.972.092.573.07